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Article
Experimental oral transmission of chronic wasting disease to red deer 
(Cervus elaphus elaphus): Early detection and late stage distribution 
of protease-resistant prion protein
Aru Balachandran, Noel P. Harrington, James Algire, Andrei Soutyrine, Terry R. Spraker,  
Martin Jeffrey, Lorenzo González, Katherine I. O’Rourke
Abstract — Chronic wasting disease (CWD), an important emerging prion disease of cervids, is readily transmit-
ted by intracerebral or oral inoculation from deer-to-deer and elk-to-elk, suggesting the latter is a natural route of 
exposure. Studies of host range susceptibility to oral infection, particularly of those species found in habitats where 
CWD currently exists are imperative. This report describes the experimental transmission of CWD to red deer 
following oral inoculation with infectious CWD material of elk origin. At 18 to 20 months post-inoculation, mild 
to moderate neurological signs and weight loss were observed and animals were euthanized and tested using 3 con-
ventional immunological assays. The data indicate that red deer are susceptible to oral challenge and that tissues 
currently used for CWD diagnosis show strong abnormal prion (PrPCWD) accumulation. Widespread peripheral 
PrPCWD deposition involves lymphoreticular tissues, endocrine tissues, and cardiac muscle and suggests a potential 
source of prion infectivity, a means of horizontal transmission and carrier state.
Résumé — Transmission orale expérimentale de la maladie du dépérissement chronique aux wapitis (Cervus 
elaphus elaphus) : Dépistage précoce et répartition de la protéine du prion résistante à la protéase aux derniers 
stades. La maladie du dépérissement chronique (MDC), une importante maladie à prions des cervidés qui est 
émergente, se transmet facilement par inoculation intracérébrale ou orale d’un cerf à un cerf et d’un wapiti à un 
wapiti, suggérant que cette dernière est une voie naturelle d’exposition. Des études sur l’ampleur de la susceptibilité 
de l’hôte à l’infection orale, particulièrement chez les espèces trouvées dans des habitats où se trouve la MDC, sont 
impératives. Ce rapport décrit la transmission expérimentale de la MDC aux wapitis après l’inoculation orale avec 
des produits infectants de MDC provenant des wapitis. De 18 à 20 mois après l’inoculation, des signes 
neurologiques de légers à modérés et la perte de poids ont été observés et les animaux ont été euthanasiés et testés 
à l’aide de 3 essais immunologiques conventionnels. Les données indiquent que les wapitis sont susceptibles aux 
infections défis orales et que les tissus actuellement utilisés pour le diagnostic de MDC montrent une accumulation 
anormalement élevée de prions (PrPCWD). Un dépôt périphérique généralisé de PrPCWD vise les tissus 
lymphoréticulaires, les tissus endocriniens et le muscle cardiaque et suggère une source potentielle d’infectivité des 
prions, un mode de transmission horizontale et un état de porteur.
(Traduit par Isabelle Vallières)
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Introduction
Chronic wasting disease (CWD), a naturally occurring trans-
missible spongiform encephalopathy (TSE), is an enigmatic 
and contagious prion disease of North American cervids that 
has been described in both captive and free-ranging animals 
including mule deer (Odocoileus hemionus), Rocky Mountain elk 
(Cervus elaphus nelsoni), white-tailed deer (Odocoileus virginia-
nus), and moose (Alces alces) (1). Chronic wasting disease shares 
many clinical and pathologic features with scrapie of sheep and 
goats, bovine spongiform encephalopathy (BSE), and transmis-
sible mink encephalopathy (TME). However, CWD is unique 
among the animal TSEs because it seems more contagious than 
scrapie, BSE, or TME and is the only prion disease maintained 
in free-ranging populations. A key event in the pathogenesis of 
prion diseases, including CWD, is the conversion of a normal 
host-encoded membrane associated prion protein (PrPC) to the 
abnormal disease-associated isoform (PrPCWD) (2). It is gener-
ally believed that PrPCWD is the main or sole component of the 
infectious agent, and that the accumulation of PrPCWD within 
the central nervous system (CNS) is the primary event leading 
to neurodegeneration (3).
The emergence of CWD amongst the North American com-
mercial cervid industry, the detection of CWD in free-ranging 
cervids over an increasingly wide geographic area, and the docu-
mented inter-species transmission between cervids, together, 
raise the possibility that CWD will spread across the continent, 
and perhaps beyond. Globally, farmed deer represent a sig-
nificant alternative livestock industry with numbers exceeding 
2 000 000 in New Zealand, 1 000 000 in China, 250 000 in the 
United States, 400 000 in Russia, and 100 000 in Canada (4). 
Red deer (Cervus elaphus elaphus), the Eurasian sub-species of 
elk, were imported into Canada for the farming of venison and 
antler in the late 1980’s and early 1990’s, and the captive cervid 
industry subsequently generated red deer/elk hybrids in order 
to increase the size of the red deer stock.
Among clinical CWD cases, the highest levels of prions are 
found in the brain and spinal cord, but other tissues, particularly 
those of the lymphoreticular system (LRS), exhibit substantial 
disease associated PrPCWD accumulation (5). Currently, BSE is 
the only animal TSE regarded as a zoonosis, whereas epidemio-
logical evidence suggests that CWD has not been transmitted 
to humans (6,7). Recent reports, however, have demonstrated 
CWD infectivity in the skeletal muscle of experimentally 
infected mice (8), hamsters (9), and deer (10). Because of the 
presumed long incubation period of CWD, infectious prions 
may be present in the peripheral tissues for a considerable period 
of time before the onset of clinical signs. These findings have 
raised concerns over the potential human health risks that may 
be encountered by consuming CWD prion-contaminated meat 
(11) and highlight the need for a thorough determination of 
the distribution of CWD prions in peripheral tissues such as 
skeletal muscle.
The diagnostic hallmark of CWD infection is the detec-
tion of PrPCWD accumulation in the CNS and LRS of affected 
and preclinical animals. The medulla oblongata, at the level 
of the obex, and the retropharyngeal lymph node are the 
target tissues for CWD diagnosis of cervids. As a gold stan-
dard test, immunohistochemistry (IHC) is a sensitive and 
effective technique for detecting CWD in cervids (12) but 
is also a costly, labor-intensive, and time-consuming tech-
nique that requires skilled personnel. Laboratories conduct-
ing IHC may become overwhelmed by increasing demand to 
support large-scale CWD and other TSE surveys. To address 
these limitations, several rapid tests designed for large-volume 
sample screening have been developed including enzyme-
linked immunosorbent assay (ELISA) and Western blotting 
(WB) (13). However, the ability of such rapid tests to detect 
PrPCWD in non-CNS and non-lymphoid tissues has not been 
well described.
Although there has yet to be a reported case of natural trans-
mission to red deer, there is concern of the spread of CWD to 
this species and the potential for human exposure to cervid 
PrPCWD. This paper describes the extent and distribution of 
PrPCWD deposition in tissues from major organ systems of red 
deer after oral inoculation with infectious CWD brain material. 
Additional objectives were to evaluate lymphoid tissues from 
antemortem pre-clinical deer for PrPCWD deposition, to com-
pare the performance of IHC and ELISA for the detection of 
PrPCWD in various CNS and non-CNS tissues, and to describe 
PrPCWD Western blot glycoform patterns from infected tissues. 
This knowledge will contribute to the understanding of CWD 
pathogenesis in red deer and help in establishing diagnostic 
methods for large-scale CWD surveillance. If CWD is found 
to occur naturally in the future, this will form the basis of 
consideration for limiting the spread of CWD from red deer 
and for the protection against any potential spread of CWD 
to humans.
Materials and methods
Experimental animals and CWD inoculum
Six 2-month-old captive red deer were obtained from herds 
free from CWD and randomly assigned to inoculated (n = 4) 
and control groups (n = 2). Inoculated deer were housed in 
a Biosafety Level 2 isolation barn at the Ottawa Laboratory 
Fallowfield, Canadian Food Inspection Agency (Ottawa, 
Ontario). All experimental protocols were approved by the 
institutional Animal Care Committee and were in accordance 
with humane animal treatment requirements of the Canadian 
Council on Animal Care.
Four red deer were orally inoculated with 5 mL of a tissue 
homogenate created from a pool of 4 CWD-positive (by IHC 
and ELISA) naturally infected captive Rocky Mountain elk. 
The inoculum was prepared from brain (n = 4) tissues that 
were placed in a mechanical grinder and a final homogenate 
concentration of 40% (w/v) was made with physiological saline 
resulting in an optical density for PrPCWD of 3.5 by ELISA 
(TeSeE; Bio-Rad Laboratories, Hercules, California, USA). The 
inoculum was administered using a small syringe inserted into 
the diastema of the oral cavity. The infected deer were monitored 
daily for clinical signs over the next 18 mo. Two non-infected 
(sham-inoculated) control deer were housed separately but under 
similar conditions to the CWD-inoculated deer.
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Sample collection for pre-clinical detection 
of PrPCWD
At 214 d post-inoculation, samples of nictitating membrane and 
recto-anal mucosa associated lymphoid tissue were collected to 
assess the infection status of the deer and to evaluate the utility 
of such tissues for the pre-clinical detection of PrPCWD as previ-
ously described for sheep and other cervids (14,15).
Postmortem examination and tissue collection
When clinical signs of CWD (loss of appetite, loss of body con-
dition, salivation, mild ataxia, weakness, dehydration, drooping 
of head and ears) became evident in 2 of the 4 inoculated deer, 
all animals were humanely euthanized with pentobarbital and 
subjected to a complete postmortem examination (585 d PI). 
Representative tissues from all major organ systems were col-
lected including brain, cervical spinal cord (C1-C4), ganglia 
(dorsal root and trigeminal), peripheral nerves (brachial plexus, 
vagus, sciatic, facial, radial, and optic), digestive, respiratory, 
cardiovascular, endocrine, musculoskeletal (triceps brachii, 
trapezius, longissimus, semitendinosus, cardiac, lingual, mas-
seter, and diaphragmatic muscles), urogenital, LRS (mesenteric, 
ileocecal, sublumbar, popliteal, pre-scapular, retropharyngeal, 
submandibular, parotid, ruminal, abomasal, hepatic, and pre-
femoral lymph nodes), and integument tissue. Duplicate samples 
of tissue from adjacent areas were taken, one of which was fixed 
in 10% neutral buffered formalin and the other stored frozen at 
270°C. The fresh brain was cut longitudinally, 1/2 being fixed 
in formalin and the remainder frozen at 270°C. The formalin 
fixed brain was cut into coronal sections, 2 to 4 mm wide. 
Eight brain areas per animal were selected for examination by 
light microscopy including the rostral cerebrum (frontal lobe), 
thalamus, midbrain (at 2 levels to include the superior colliculus 
and red nucleus), pons, medulla (at the level of the cerebellar 
peduncles and obex), and cerebellum at the vermis. Unfixed 
tissue from contralateral brain areas were sampled by ELISA 
and Western blot techniques.
Histopathology and immunohistochemistry 
(IHC)
The techniques used for histopathology and IHC were similar 
to those previously described (15,16). Tissues were embedded 
in paraffin blocks, and serial sections were cut at 5-mm intervals 
and mounted onto positively charged glass slides (Superfrost/
plus; Fisher Scientific, Ottawa, Ontario). The sections were 
either stained with hematoxylin and eosin (HE) for the occur-
rence of spongiform degeneration (brain only), or subjected to 
IHC for the presence of PrPCWD. Prior to IHC, antigen retrieval 
was performed as follows: tissue sections were immersed in 
96% formic acid (Mallinckrodt, Paris, Kentucky, USA) for 
5 min, rinsed, and placed in 100 mM Tris buffer (pH 7.6) 
for 25 min at 121°C (liquid setting) and cooled for 30 min to 
room temperature. Subsequent steps of the IHC protocol were 
performed with an automated immunostainer (Ventana Medical 
Systems, Tucson, Arizona, USA). Sections were stained with 
primary monoclonal antibody (MAb) F99/97.6.1 (VMRD, 
Pullman, Washington, USA) for 30 min at 37°C, followed 
by a biotinylated anti-mouse secondary antibody, an alkaline 
phosphatase-streptavidin conjugate, substrate chromogen (fast 
red), and a hematoxylin counterstain with bluing (Ventana). 
The primary antibody was diluted to an IgG concentration of 
5 mg/mL in diluent (Ventana) and placed in the refillable dis-
penser provided with the immunostainer. Positive and negative 
controls were included with each run.
Tissues that were positive by IHC had granular red chromo-
gen deposits that were interpreted to be PrPCWD. The abundance 
of PrPCWD was subjectively graded on a scale of 0 to 111 
based on examination at 203, with 0 = no staining, 1 = mild, 
11 = moderate, and 111 = strong. The intensity of the stain 
was bright red whether the scoring was 1, 11, or 111. Since 
the dorsal motor nucleus of the vagus (DMNV) was the most 
consistently and severely affected nucleus with regard to the 
abundance of IHC positive material, this nucleus was graded 
as strong (111) and all other sites were scored accordingly. 
Lymph nodes were considered positive if any of the follicles 
exhibited positive IHC.
ELISA and Western blot
PrPCWD purification and immunodetection by ELISA and 
Western blot were performed on unfixed tissue samples using 
commercial test kists (TeSeE ELISA and TeSeE Western blot; 
Bio-Rad) according to the manufacturer’s instructions, and as 
previously described (17). For the ELISA, the absorbance cut-
off value for PrPCWD detection was calculated by adding a fixed 
value of 0.09 to the mean optical density of the negative con-
trols (17). Western blot protein bands were identified, relative 
intensities quantified, and their molecular mass estimated with 
a Chemi Doc XRS (Bio-Rad) digital camera and the associated 
analysis software (Quantity One, version 4.6, Bio-Rad). Positive 
and negative control PrPCWD samples from CWD elk brain were 
run on all Western blots throughout the study. Samples were 
considered positive if the prion protein bands specific to the 
PK-resistant core of PrPCWD were detected.
Figure 1. Immunohistochemistry (IHC) detection of PrPCWD in 
rectal biopsy sample from a red deer (Cervus elaphus elaphus) 
214 d after oral inoculation with infectious CWD material. 
Lymphoid follicles beneath the rectal epithelium have variable 
degrees of immunolabelling associated with tingible body 
macrophages and follicular dendritic cells. Monoclonal antibody 
F99/97.6.1 and hematoxylin counterstaining. Bar = 150 mm.
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Figure 2. Immunohistochemistry (IHC) detection of PrPCWD using MAb F99/97.6.1 in various tissues of orally 
inoculated red deer (Cervus elaphus elaphus) with CWD.
(a) –  Brain, medulla oblongata, obex, dorsal motor nucleus of vagus nucleus. There is moderate diffuse vacuolation  
of the neuropil and also occasional presence of vacuoles within neuronal perikarya. Hematoxylin & eosin.  
Bar = 30 mm.
(b) –  Brain, medulla oblongata, obex. There is extensive accumulation of PrPCWD (stained red) predominantly in the 
neuropil and with prominent perineuronal labelling. IHC. Bar = 70 mm. 
(c) – Tonsil. Detection of PrPCWD in tonsillar lymphoid follicles. IHC. Bar = 275 mm.
(d) – Colon, myenteric plexus. IHC. Bar = 70 mm.
(e) – Adrenal gland, medulla. IHC. Bar = 70 mm.
(f) – Heart, ventricular septum. IHC. Bar = 40 mm.
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PRNP genotyping
Genomic DNA from blood or tissue samples of experimental red 
deer was subject to PCR amplification and sequence analysis of 
the PRNP open reading frame as described for Rocky Mountain 
elk (18).
Results
Pre-clinical detection of PrPCWD
Samples of nictitating membrane collected at 214 d PI were 
negative by IHC and ELISA for all infected deer. Rectal lym-
phoid tissue collected at the same time was positive for PrPCWD 
by IHC (Figure 1) but negative by ELISA for all infected deer.
Clinical signs and postmortem examination
At 576 d PI, one of the inoculated deer (No. 103) began to show 
subtle variable clinical signs consistent with CWD. Abnormal 
neurological signs included ataxia, hyperexcitability, trembling, 
weakness, isolation, standing with lowered head, and hyper-
salivation. The affected animal consumed reduced amounts of 
feed leading to a gradual loss of body condition. After a second 
infected deer (No. 105) began to show similar clinical signs at 
583 d PI, all deer were euthanized and subject to postmortem 
examination. The primary gross lesions were emaciation accom-
panied by generalized absence or serous atrophy of subcutane-
ous and abdominal adipose tissue and yellow gelatinous bone 
marrow. All inoculated animals were otherwise normal and no 
lesions were found in control deer.
Histopathology
Spongiform encephalopathy was observed in the brain of the 
4 infected deer and was characterized by severe and widespread 
microcavitation primarily of the grey matter, single or multiple 
intracytoplasmic vacuolation of neurons, neuronal degeneration 
and loss, mild astrocytic hypertrophy and hyperplasia, and the 
absence of any significant inflammatory response (Figure 2a). 
The severity of spongiform change varied in the grey matter of 
the medulla oblongata, pons, thalamus, and cerebral cortex. 
Specific areas consistently most severely affected included olfac-
tory bulbs, thalamic nucleus, supraoptic nucleus, paraventricular 
nucleus, reticular formation, hypoglossal nucleus, parasympa-
thetic nucleus nucleus of the vagus nerve, medial and lateral 
cuneatus nuclei, and nucleus of the spinal tract of the trigeminal 
nerve. No lesions suggestive of spongiform encephalopathy were 
seen in the control deer.
Tissue distribution of PrPCWD by IHC and ELISA
The results of a comparative assessment of PrPCWD signal inten-
sity obtained by IHC and the ELISA rapid test for various brain 
and spinal cord areas are shown in Table 1. Both tests detected 
high levels of PrPCWD from all areas of the brain and spinal 
cord. The pattern of staining was consistent amongst inoculated 
animals. The immunolabeling pattern consisted of coarse, granu-
lar, or particulate deposits of red chromogen. The labelled foci 
were located primarily in grey matter, but sometimes appeared 
in white matter, especially in the rostral cerebrum. The loca-
tion of PrPCWD was often perineuronal, forming a ring around 
the cell (Figure 2b). Neuropil accumulations were of the fine 
particulate type, with some more coarse and linear deposits in 
severely affected areas. The most severely affected brain areas 
were the midbrain and medulla where foci were so numerous 
and large that they often formed large confluent areas. Granular 
deposits of PrPCWD within the cytoplasm of neurons were 
prominent, especially throughout the brainstem and thalamic 
nuclei. Intracellular deposits of PrPCWD were also noticeable 
in astrocytes and microglial cells in areas of heavy neuropil 
involvement. In the spinal cord, fine punctuate or coarse par-
ticulate neuropil-type accumulation of PrPCWD was greatest in 
the dorsal horns but at reduced levels as compared to the brain. 
The eyes of affected deer had consistent PrPCWD distribution by 
IHC in the optic nerve fibers, the layer of ganglion cells, and 
the inner and outer plexiform layers of the retina. The ELISA 
detected PrPCWD from the adjacently sampled ocular areas in 
3 of 4 CWD infected deer.
In addition to the CNS, PrPCWD was detected by IHC and 
ELISA in a variety of other tissues including lymphoid tissue, 
nerve ganglia (trigeminal and dorsal root), endocrine tissues 
(adrenal gland, pancreas, and pars nervosa of the pituitary 
gland), cardiac muscle, the myenteric plexus of most gastroin-
testinal tissues, and nasal mucosa (Table 2).
Chromogen staining consistent with PrPCWD was observed in 
the germinal centers of the tonsil, gut-associated lymphoid tissue 
(GALT), and all lymph nodes. The PrPCWD deposition was char-
acterized by bright red granular material filling germinal centers 
of 50% to 95% of follicles (Figure 2c). The staining pattern was 
Table 1. PrPCWD distribution and comparative subjective assessment of the signal intensities of immunohistochemistry (IHC) and enzyme-
linked immunosorbent assay (ELISA) from different brain and spinal cord regions from 4 orally inoculated CWD-positive red deer (Cervus 
elaphus elaphus)
Animala
 Spinal cordb Brainstem Cerebellum Midbrain Thalamus Cerebrum
ID IHCc ELISAd IHC ELISA IHC ELISA IHC ELISA IHC ELISA IHC ELISA
101 111 3.226 111 . 3.5 111 3.016 111 . 3.5 111 . 3.5 11 1.983
103a 111 2.570 111 2.749 111 2.543 11 2.739 11 2.866 111 2.614
105a 111 3.165 111 3.042 111 2.331 111 3.014 111 2.995 111 3.010
106 111 3.227 111 . 3.5 11 1.362 111 3.434 111 . 3.5 11 1.736
a Animals no. 103 and 105 developed clinical signs at 576 and 583 d post-inoculation, respectively. All deer were subsequently euthanized and subjected to postmortem 
examination and PrPCWD testing.
b Sample of cervical spinal cord (C1-C4).
c PrPCWD was detected by IHC with MAb F99/97.6.6 with the scoring system (1 to 111) described in Materials and methods.
d Optical density (OD) data from Bio-Rad Laboratories’ ELISA.
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morphologically consistent with that of follicular dendritic cells 
within germinal centers of well-developed secondary follicles. 
Staining often occurred in clusters of adjacent follicles.
The ELISA results were in general agreement with IHC 
results, but were slightly less sensitive. Of 62 lymphoid tissues 
tested, ELISA and IHC classified 42 and 57 tissues as positive, 
respectively. PrPCWD was detected from each lymph node in at 
least 1 animal. For tissues reported to have potential preclinical 
CWD diagnostic utility, IHC detected PrPCWD in tonsil and 
rectal lymphoid tissue from all inoculated deer whereas ELISA 
classified 3 of 4 tonsil and 1 of 4 rectal lymphoid tissues as 
CWD positive.
Positive IHC and ELISA results were found in virtually all 
gastrointestinal tissues including the parotid and mandibular 
salivary glands, the myenteric plexus of rumen, abomasum, small 
intestine, ileum, and colon. Deposition of PrPCWD was located 
in the GALT with a pattern analogous to other lymphoid fol-
licles. Perineuronal staining was present within the submucosal 
and myenteric plexuses (Figure 2d).
Positive IHC and ELISA results were found in several neuro-
endocrine tissues including the pancreas, thyroid, adrenal, and 
pituitary glands. The pancreas of 2 of 4 CWD-positive deer con-
tained coarse granular PrPCWD deposits confined to the islets of 
Langerhans. One of these deer was also classified as positive by 
ELISA. One animal had PrPCWD detected in the thyroid gland 
with deposits located along the apical surface of parafollicular 
cells. In the pituitary glands of all CWD-positive deer (IHC 
and ELISA), PrPCWD deposits were evident, primarily in the 
pars nervosa and intermedia. Similarly, PrPCWD was detected in 
the adrenal glands of 3 deer by IHC and ELISA. Staining was 
restricted to the medulla where large columnar cells appeared to 
have PrPCWD deposits intracellularly and associated with the cell 
surface (Figure 2e). The PrPCWD deposits were large and angular 
as opposed to small and granular as reported in other tissues.
The ventricular myocardium of all 4 infected deer showed 
PrPCWD deposition consisting of readily visible punctuate 
granules of chromogen scattered in apparently cell-associated 
fashion more prominent in longitudinal than in transverse 
cross-sections of cardiac myocytes. Groups of positive adjacent 
myocytes were surrounded by cells with no detectable stain 
(Figure 2f ). Epicardial nerves and ganglia and subendocardial 
and myocardial Purkinje fibers lacked detectable PrPCWD stain-
ing. Cardiac muscle was also strongly positive by ELISA in 2 of 
4 inoculated deer (Table 2).
Of the respiratory tissues, only the nasal mucosa was ELISA 
and IHC positive for PrPCWD. No PrPCWD was detected by IHC 
Table 2. Comparison of immunohistochemical (IHC) staining and enzyme-linked immunosorbent assay 
(ELISA) detection of PrPCWD in selected tissues from 4 orally-inoculated CWD-positive red deer 
(Cervus elaphus elaphus)
 Detection  Detection
 of PrPCWD of PrPCWD
System, anatomical sites ELISA IHCa System, anatomical sites ELISA IHC
Central nervous system    Pre-femoral LN 1/4 3/4
 Eye 3/4b 4/4  Popliteal LN 4/4 3/4
 Cervical spinal cord (C1-C3): 4/4 4/4  Spleen 3/4 3/4
 Medulla (at obex) 4/4 4/4  Tonsil 3/4 4/4
 Rostral medulla 4/4 4/4 Digestive system
 Midbrain 4/4 4/4  Submandibular salivary gland 2/4 0/4
 Thalamus 4/4 4/4  Parotid salivary gland 2/4 1/4
 Frontal cortex 4/4 4/4  Reticulum 3/4 4/4
 Cerebellum/vermis 4/4 4/4  Rumen 0/4 2/4
Peripheral nervous system    Abomasum 1/4 4/4
 Trigeminal ganglia 1/4 4/4  Duodenum 2/3 3/3
 Dorsal root ganglia 0/3c 3/3  Jejunum 0/4 4/4
 Sympathetic trunk 0/4 0/4  Ileum 4/4 4/4
 Vagus nerve 0/4 0/4  Proximal Colon 3/4 4/4
 Sciatic nerve 0/4 0/4  Distal Colon 1/4 4/4
 Radial nerve 0/4 0/4 Respiratory system
 Facial nerve 0/4 0/4  Nasal mucosa 3/3 2/4
 Brachial plexus 0/4 0/4  Lung 0/4 0/4
Lymphoreticular system   Endocrine system
 Rectal lymphoid tissue 2/4 4/4  Pancreas 1/4 2/4
 Peyer’s Patches 3/4 4/4  Thyroid Gland 0/4 1/4
 Retropharyngeal LN 3/4 4/4  Adrenal Gland 3/3 3/3
 Parotid LN 3/4 4/4  Pituitary Gland 4/4 4/4
 Submandibular LN 3/4 4/4 Musculoskeletal system
 Pre-Scapular LN 1/4 3/4  Diaphragm 0/4 0/4
 Hepatic LN 3/4 4/4  Masseter muscle 0/4 0/4
 Ruminal LN 3/3 3/4  Triceps brachii muscle 0/4 0/4
 Abomasal LN 3/3 3/3  Longissimus thoracis muscle 0/4 0/4
 Mesenteric LN 4/4 4/4  Semitendinosus muscle 0/4 0/4
 Ileocecal LN 4/4 4/4
 Sublumbar LN 2/3 3/3  Heart 2/4 4/4
a PrPCWD was detected by IHC with MAb F99/97.6.6.
b Results are expressed as the number of test positive animals over the total number of animals examined.
c Some tissues were not available for examination.
LN = lymph node.
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or ELISA in the following tissues: skeletal striated muscle, kid-
ney, urinary bladder, ovary, uterus, and testis. In addition, no 
PrPCWD was detected in any tissue of control deer.
Western blot
Western blot analysis was performed on selected samples includ-
ing brainstem, skeletal muscle, cardiac muscle, adrenal gland, 
pancreas, thyroid gland, and nasal mucosa. For the brainstem, 
tissue was taken and homogenates prepared from the medulla 
contralateral to the section taken for IHC. The brainstem of 
all inoculated deer was positive by this method, showing the 
characteristic banding pattern of the TSEs (Figure 3). The pro-
files of 3 bands of proteinase K-resistant isoforms of PrPCWD, 
di-, mono-, and unglycosylated, were comparable in molecular 
weight and glycoform ratio to those of the original inoculum. 
The 2 control deer had no detectable PrPCWD in the brainstem 
by Western blot.
The Western blot findings were consistent with IHC and 
ELISA for PrPCWD detection in selected extraneural tissues 
including cardiac muscle, pancreas, thyroid, and adrenal gland. 
For example, the adrenal glands, which demonstrated abun-
dant PrPCWD by IHC and ELISA, also showed strong banding 
pattern signals by Western blot. In contrast, we were unable 
to demonstrate the presence of PrPCWD in the skeletal striated 
muscle of any deer.
PRNP genotype
The DNA sequence of the open reading frame of the PRNP gene 
from the 4 inoculated red deer in this study was similar to that 
reported previously for C. elaphus elaphus, with a single coding 
polymorphism (glutamic acid E and glutamine Q) at codon 226 
(GenBank P67987 and AY748455) (19) with a synonymous 
change (GCC to GCT) at codon 106 on the allele encoding 
226Q. Samples from all 4 animals encoded methionine at 
codon 132, glycine at codon 96, and serine at codon 225, sites 
associated with prion disease progression in Rocky Mountain 
elk, white-tailed deer, and mule deer, respectively. Red deer 105 
was homozygous for 226E, red deer 106 was homozygous for 
226Q, and red deer 101 and 103 were heterozygous for the non-
synonymous (226EQ) and synonymous (106 gcc/gct) changes.
Discussion
Until recently, only 3 species, all members of the Family 
Cervidae, were known to be naturally susceptible to CWD, 
namely: mule deer, white-tailed deer, and Rocky Mountain elk. 
In 2005, however, a free-ranging moose (Alces alces) was found 
to be infected with CWD (20) and moose were shown to be 
susceptible to experimental CWD (21). Although a natural 
case CWD infection has yet to be reported for red deer, this 
study indicates that the potential for it to occur exists. This was 
expected given that elk and red deer are of the same genus and 
species (Cervus elaphus).
As with other TSEs, CWD is characterized by a long incuba-
tion period which, in deer, is seldom less than 18 mo. Although 
only subtle clinical signs of CWD were evident in 2 of 4 inocu-
lated animals, the neurological lesions were quite obvious his-
tologically for all 4 deer. The distribution and severity of these 
lesions were consistent with those previously reported for CWD 
in other cervid species (22,23) and qualitatively similar to those 
described for the other spongiform encephalopathies (24).
Immunohistochemistry has demonstrated the accumulation 
of CWD-specific prion protein in the brain, spinal cord, nerves, 
and ganglia of the peripheral nervous system, lymphoid tissues, 
and in endocrine tissues of clinical cases (25,26). This study 
demonstrates that red deer develop detectable PrPCWD after oral 
exposure to an inoculum containing CWD prions and provides 
Figure 3. Western blot analysis of the prion protein proteinase K-resistant core (PrPres of PrPCWD) from 
the homogenates of the medulla oblongata of orally inoculated red deer (Cervus elaphus elaphus). The 
positive banding pattern of 4 red deer samples (deer no. 101, 103, 105, and 106 in triplicate) is compared 
with that of a previously characterized positive control sample from a captive CWD-affected elk. Animals 
no. 103 and 105 developed clinical signs at 576 and 583 days post-inoculation respectively. All deer were 
subsequently euthanized and subject to post-mortem examination and PrPCWD testing. Protein molecular 
weight (MW) markers are shown on the left in kilodaltons. A negative control sample is shown on the right 
(deer no. 104).
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knowledge about the tissue pattern of PrPCWD accumulation at 
the terminal stages of disease. The pattern of PrPCWD deposi-
tion in the brain was consistent with previous descriptions of 
naturally CWD-infected cervids (23,27). PrPCWD deposition 
was observed in all areas of spongiform encephalopathy, but in 
many areas where PrPCWD was present, spongiform degenera-
tion was not found.
The PrPCWD was deposited in follicles of almost all lymphoid 
tissues, including those of the digestive tract, tonsil, and lymph 
nodes as has been shown to be the case for other CWD-infected 
cervids (23), and scrapie-infected sheep and goats (28,29). 
Sigurdson et al (30) demonstrated PrPCWD in tonsil and alimen-
tary tract-associated lymphoid tissues of mule deer fawns as early 
as 42 d after they were orally inoculated with brain tissue from 
captive deer dying of CWD. The pre-clinical detection PrPCWD 
and the abundance of PrPCWD in the lymphoid tissues at post-
mortem in the present study suggest that lymphoid tissues of 
this species may play a role in the pathogenesis and transmission. 
Such disseminated lymphoid infection contrasts with some other 
TSEs, such as BSE, in which PrPBSE is detected only in the ileal 
Peyer’s patches or not at all (31). Similarly, recent experimental 
transmission of BSE to red deer found PrPBSE restricted to the 
central and peripheral nervous systems (32).
There is a strong correlation between the presence of PrPTSE 
and infectivity in prion diseases. Although the epidemiologic 
evidence strongly suggests that CWD is not transmissible to 
humans, this study and others suggest caution in this regard. 
The finding of PrPCWD in various organs, albeit in clinical 
CWD, suggests that humans who consume or handle meat from 
CWD-infected red deer may be at risk of exposure to CWD 
prions. This study found that red deer tissues other than ner-
vous and lymphoid tissue can support CWD prion replication 
and accumulation. As a result, the consumption or handling 
of meat from CWD-infected red deer will put humans at risk 
of exposure to CWD prions. In spite of a well-documented 
species barrier, a cautious approach would involve preventing 
such tissues from entering the animal and human food chains. 
Future studies will require sensitive and quantitative techniques 
such as bioassays in transgenic mice that assess tissue infectivity 
and quantitative immunoassays adapted to PrPCWD detection in 
peripheral tissues.
The presence of PrPCWD in the left ventricular myocardium 
was probably due to dissemination by peripheral nerves, as this 
phenomenon has also been observed in CWD-infected mule 
deer, white-tailed deer, and elk (33,34). It is not known whether 
the prions that were detected in cardiac tissue were localized to 
nerve fibers or subcellular structures within myocytes.
Substantial deposits of PrPCWD were detected by IHC and 
ELISA in the adrenal medulla and pancreatic islet cells, and 
lesser amounts in the thyroid gland. Infectivity in the pancreas 
and adrenal medulla, which are innervated by splanchnic nerves 
and the vagus nerve, respectively, has been documented in 
natural and experimentally infected scrapie and CWD (25,35). 
PrP-containing islet cells and glandular cells of the adrenal 
medulla were often adjacent, which might suggest infection 
from a common nidus, such as innervation by a common nerve 
branch. Although PrPCWD has not been reported previously in 
the thyroid gland, the normal cellular isoform of prion protein 
(PrPC) has (36), indicative of the potential for conversion to 
PrPCWD. We also documented PrPCWD in the pars interme-
dia and nervosa of the pituitary in CWD-infected red deer. 
Potentially, PrPCWD could transit via nerve fibers from the hypo-
thalamus to the pars nervosa, as the deer had abundant PrPCWD 
in the hypothalamus. Given the recent report demonstrating 
CWD infectivity of skeletal muscle tissue when inoculated into 
transgenic mice (10), the present study rigorously tested for 
PrPCWD deposits in the skeletal muscles of inoculated red deer. 
Importantly, no PrPCWD deposition was detected in any stri-
ated skeletal muscle using conventional methods. This finding 
corroborates similar negative observations in cervids made by 
others (26,33,37). Cardiac muscle differs from skeletal muscle 
in its structure, physiology, and innervation; one or more of 
these factors may underlie the difference in PrPCWD deposition 
between skeletal and cardiac muscle for cervids. Glatzel et al (38) 
proposed a positive correlation between the duration of disease 
and the detection of PrPCWD in muscle. A longer duration of 
clinical disease, therefore, may have increased the likelihood of 
detecting PrPCWD in muscle.
The exact mode of transmission of CWD in nature remains 
unclear but is believed to involve direct animal-to-animal 
contact or environmental contamination. As TSE agents are 
extremely resistant in the environment (39), oral exposure is 
the most plausible pathway by which the CWD prion may be 
introduced to deer in nature and represents a significant obstacle 
to eradication of CWD from either farmed or free-ranging cer-
vid populations. The distribution of PrPCWD in gut-associated 
lymphoid tissues, salivary glands, and nasal mucosa in the red 
deer of this study suggests potential routes of PrPCWD shedding 
into the environment via fluids such as saliva or feces. However, 
this study did not identify the point at which an animal may 
become infectious during the course of infection. An improved 
understanding of the mechanisms of shedding and transmission 
will be important in the future management of CWD.
The general pattern of PrPCWD accumulation in cervids 
with CWD is characterized by relatively rapid and widespread 
involvement of lymphatic tissues, followed by progressive 
involvement of, and lesions in, central and peripheral nervous 
tissues, with involvement of a wider variety of tissues and 
organs as animals become terminally ill (34). Assuming the 
immunobiology of red deer is similar to that of other cervids 
and sheep, it seems probable that initial uptake and propagation 
of PrPCWD may occur in the lymphoid tissues draining the oral 
and intestinal mucosa (the retropharyngeal lymph nodes, tonsil, 
ileal Peyer’s patches, and ileocecal lymph nodes). The finding of 
PrPCWD in rectal lymphoid tissues as early as 7 months PI sup-
ports such a model for red deer.
The appearance of PrPCWD in myenteric and submucosal 
plexuses of the gastrointestinal tract and in brain and spinal 
cord is consistent with the hypothesis that autonomic innerva-
tions, particularly of enteric tissues, plays a role in the spread 
of PrPCWD from peripheral tissues to the CNS (25,40). The 
gastrointestinal tract receives parasympathetic vagal fibers from 
the DMNV and sympathetic nerve fibers from the spinal cord. 
PrPCWD was not detected either by ELISA, IHC or Western blot 
CVJ / VOL 51 / FEBRUARY 2010 177
A
R
T
IC
L
E
in various peripheral nerves including the brachial plexus, vagus 
nerve, sciatic nerve, radial nerve, and vagosympathetic trunk 
(data not shown). The inability to find PrPCWD in the vagus 
nerve was especially surprising given that this is the presumed 
primary path of transmission of PrPCWD to the DMNV of the 
brain (25). This observation, however, is consistent with others 
(23) and perhaps is due to concentrations below the thresh-
old of detection by any of IHC, ELISA, or WB. PrPCWD was 
detected, however, in both trigeminal and dorsal root ganglia 
(Table 2) consistent with the ascending transmission hypothesis. 
Alternatively, other routes of PrPCWD transit, such as blood, 
cannot be excluded.
The Bio-Rad ELISA has been an effective diagnostic tool 
for screening obex or retropharyngeal lymph node tissues from 
deer and elk for evidence of CWD infection (17). The results 
presented here show that rapid tests are also able to detect 
PrPCWD from various other tissues of CWD-infected red deer. 
ELISA and WB rapid tests revealed essentially the same PrPCWD 
distribution pattern in tissues as was shown with IHC. However, 
ELISA generally classified fewer tissues as PrPCWD positive than 
did IHC. Discrepancies between ELISA and IHC tended to 
occur in tissues where PrPCWD deposition was sporadic or patchy 
such as heart, adrenal gland, salivary gland, and in preclinical 
rectal biopsies. The rapid tests require small samples of tissue 
to produce a homogenate for further analysis which may, as a 
result, contain few if any foci of PrPCWD deposition. By contrast, 
IHC allows for the examination of a large area of a tissue.
For cost-effective surveillance programs it is essential to iden-
tify the appropriate tissues for testing, and the present findings 
have implications for the screening methods for the detection 
of CWD in red deer. Currently, the obex and retropharyngeal 
lymph node are the tissues of choice when postmortem sampling 
for the diagnosis of CWD in cervids that are early in infection. 
Although additional examinations of field samples and animals 
at various stages of infection are required, this study supports 
the examination of brain and at least 1 lymphoid tissue to detect 
the disease at postmortem in most infected red deer. Both IHC 
and ELISA identified PrPCWD in the obex of all inoculated deer 
at postmortem, whereas IHC was more sensitive than ELISA for 
lymphoid tissues including the retropharyngeal lymph node and 
tonsil. When brainstem is not available (for example, autolysis), 
the data suggest that, for C. elaphus species, testing other avail-
able CNS areas including cervical spinal cord, thalamus, or 
cerebellum is preferred to testing lymphoid tissue alone.
The successful eradication of CWD from captive deer herds 
will require an accurate diagnostic test to identify infected ani-
mals during early pre-clinical stages of the disease. Recently, the 
early accumulation of PrPCWD in accessible peripheral lymphoid 
tissues such as the tonsil and rectum has become a potential 
pre-clinical antemortem indicator of disease (41,42). This study 
supports the use of these accessible lymphoid tissues for CWD 
surveillance of red deer, with IHC showing greater sensitivity 
than ELISA.
Differences in the apparent molecular weight and relative 
abundance of the 3 PrPCWD glycoforms (di-, mono-, and un-
glycosylated) after they have been separated on polyacrylamide 
gels indicate differences between TSEs associated with different 
species as well as strain differences for particular TSEs (43,44). 
Western blot of the brainstem of all CWD-inoculated red deer 
demonstrated a glycoform banding pattern identical to that of 
the tested extraneural tissues and the inoculum prepared from 
previously characterized captive elk (Figure 3).
The primary sequence of the prion protein precursor is associ-
ated with prevalence, incubation time, and proteolytic cleavage 
sites in some cervid species exposed to CWD. A polymorphism 
(methionine M to leucine L) at PRNP codon 132 is associated 
with increased incubation time and a novel protease cleav-
age site in PrPCWD of Rocky Mountain elk with experimental 
disease and in a transgenic rodent model (45,46), although its 
association with CWD prevalence varies (47). A coding change 
was identified at codon 226, which encodes glutamic acid (E) 
in C. elaphus canadensis (48) and C. elaphus nelsoni (49) and 
glutamine (Q) in Hemionus spp. in North America. The site 
is polymorphic in red deer [(19) and unpublished data shown 
in GenBank AY748455] and all 3 diploid genotypes (EE, QQ, 
EQ) were represented in this study. There were no differences 
in Western blot profile or incubation time associated with these 
genotypes. If the effect of genotype on natural disease is similar 
to that observed in this study, the polymorphism is unlikely to 
affect disease progression or diagnostic testing.
In summary, this study demonstrates the potential for oral 
transmission of CWD to red deer and describes the pattern 
of PrPCWD accumulation for this species. The current surveil-
lance testing regime for cervids would be expected to identify 
CWD-infected red deer should it occur in North America. 
These results confirm the usefulness of rapid tests such as 
ELISA but with generally slightly lower sensitivity when com-
pared with IHC when testing tissues with patchy or sporadic 
PrPCWD deposition. The finding of PrPCWD in several extra-
neural tissues including cardiac muscle and the endocrine 
system suggests that further investigation and monitoring of 
the potential transmissibility to other species including humans 
is warranted.
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